During the first quarter of the year, Meds' net sales amounted to SEK 269.9 million, representing an increase of 11.6 percent. The gross profit for the period amounted to SEK 75 million. The company reports an adjusted operating profit (EBIT) of SEK 5.2 million, which resulted in an adjusted EBIT margin of 1.9 percent.
Cash flow from operating activities also strengthened during the period, amounting to SEK 35.3 million. At the end of the quarter, the company's liquid funds amounted to SEK 71.5 million.
The revenue increase was primarily driven by the prescription segment, which increased by 34.4 percent during the quarter.
Prescription products were once again the strongest growth engine with a 35 percent increase. The trend is clear and stable - more and more Swedes are choosing to have their medicine delivered to their homes instead of visiting a pharmacy, says Meds CEO and co-founder Björn Thorngren.
"Without Financial Risk"
During the quarter, the online pharmacy signed an agreement for a new warehouse premises with access date August 1, 2026. The new facility is expected to nearly triple the company's current warehouse area. The move is primarily planned to be carried out during the second half of the third quarter.
READ ALSO: Meds Moves - Takes Over New Base: "Strong and Expansive"
Ahead of commissioning, the company is making investments in strengthened automation capacity in packing and order sorting. Agreements have been signed with suppliers Ranpak and E-motions to build a modular solution with the capacity to handle tens of thousands of packages per day, the company says.
We continue to scale the business cost-effectively with well-proven and efficient automation. Through controlled investments, we ensure continued deliveries throughout Sweden without financial and operational risk, says Björn Thorngren.